Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245851772881
Publisher
SAGE Publications
Online
2017-08-31
DOI
10.1177/1352458517728811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
- (2017) Luanne M. Metz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome
- (2016) Maria Laura Bertolaccini et al. JOURNAL OF AUTOIMMUNITY
- Complement is activated in progressive multiple sclerosis cortical grey matter lesions
- (2016) Lewis M. Watkins et al. Journal of Neuroinflammation
- An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination
- (2016) Michael B. Keough et al. Nature Communications
- Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis
- (2015) Mika Komori et al. ANNALS OF NEUROLOGY
- Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
- (2015) Brit Fitzner et al. AUTOIMMUNITY REVIEWS
- Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration
- (2015) Rebecca Scholz et al. Journal of Neuroinflammation
- Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis
- (2015) Marcus W. Koch et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Multiple sclerosis—a quiet revolution
- (2015) Richard M. Ransohoff et al. Nature Reviews Neurology
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
- (2014) Manuel A. Friese et al. Nature Reviews Neurology
- Iron and neurodegeneration in the multiple sclerosis brain
- (2013) Simon Hametner et al. ANNALS OF NEUROLOGY
- Reduction of microglial activity in a model of multiple sclerosis by dipyridamole
- (2013) Scott Sloka et al. Journal of Neuroinflammation
- Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
- (2013) Jeppe Romme Christensen et al. PLoS One
- Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis
- (2013) David W Hampton et al. Acta Neuropathologica Communications
- NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury
- (2012) Marie T. Fischer et al. BRAIN
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis
- (2011) Sarah Al-Izki et al. Multiple Sclerosis Journal
- Matrix Metalloproteinase-12 Deficiency Worsens Relapsing-Remitting Experimental Autoimmune Encephalomyelitis in Association with Cytokine and Chemokine Dysregulation
- (2009) Angelika Goncalves DaSilva et al. AMERICAN JOURNAL OF PATHOLOGY
- Different methods for control and comparison of the antioxidant properties of vegetables
- (2009) Milan Číž et al. FOOD CONTROL
- Glatiramer acetate in combination with minocycline in patients with relapsing—remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
- (2009) LM Metz et al. Multiple Sclerosis Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now